55
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis

, , , , &
Pages 2695-2709 | Published online: 15 Aug 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ya-Ming Xie, Wenfeng Lu, Jian Cheng, Mugen Dai, Si-Yu Liu, Dong-Dong Wang, Tian-Wei Fu, Tai-Wei Ye, Jun-Wei Liu, Cheng-Wu Zhang, Dong-Sheng Huang & Lei Liang. (2023) Naples Prognostic Score is an Independent Prognostic Factor in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 10, pages 1423-1433.
Read now
Federica Cavalcoli, Sara Pusceddu, Alessandra Zilli, Gianluca Tamagno, Daniela Femia, Natalie Prinzi, John Travers, Dario Consonni, Clorinda Ciafardini, Dario Conte & Sara Massironi. (2019) Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm. Scandinavian Journal of Gastroenterology 54:9, pages 1111-1117.
Read now

Articles from other publishers (26)

思远 张. (2024) Research Progress on the Impact of Platelets on the Occurrence, Development, and Treatment of Liver Cancer. Advances in Clinical Medicine 14:03, pages 541-546.
Crossref
Xindan Kang, Jing Wang, Xue Kang & Li Bai. (2023) Predictive value of prognostic nutritional index (PNI) in recurrent or unresectable hepatocellular carcinoma received anti-PD1 therapy. BMC Cancer 23:1.
Crossref
Oliver Oey, Angela Felicia Sunjaya, Yasir Khan & Andrew Redfern. (2023) Stromal inflammation, fibrosis and cancer: An old intuition with promising potential. World Journal of Clinical Oncology 14:7, pages 230-246.
Crossref
Jonathan Abdelmalak, Natassia Tan, Danny Con, Guy Eslick, Ammar Majeed, William Kemp & Stuart K. Roberts. (2023) The Effect of Aspirin Use on Incident Hepatocellular Carcinoma—An Updated Systematic Review and Meta-Analysis. Cancers 15:13, pages 3518.
Crossref
Can G. Leineweber, Miriam Rabehl, Anne Pietzner, Nadine Rohwer, Michael Rothe, Maciej Pech, Bruno Sangro, Rohini Sharma, Chris Verslype, Bristi Basu, Christian Sengel, Jens Ricke, Nils Helge Schebb, Karsten-H. Weylandt & Julia Benckert. (2023) Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma. Frontiers in Pharmacology 14.
Crossref
Cuilan Chen, Ting Liang, Qihui Wu, Zheyi Zhou, Mingmin Zhang, Dongshan Feng, Jingrui Tao, Tao Si & Min Cai. (2022) Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2022, pages 1-15.
Crossref
Lun-Jie Yan, Sheng-Yu Yao, Hai-Chao Li, Guang-Xiao Meng, Kai-Xuan Liu, Zi-Niu Ding, Jian-Guo Hong, Zhi-Qiang Chen, Zhao-Ru Dong & Tao Li. (2022) Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis. Journal of Clinical and Translational Hepatology 10:5, pages 835-846.
Crossref
Nidheesh Thadathil, Ramasamy Selvarani, Sabira Mohammed, Evan H. Nicklas, Albert L. Tran, Maria Kamal, Wenyi Luo, Jacob L. Brown, Marcus M. Lawrence, Agnieszka K. Borowik, Benjamin F. Miller, Holly Van Remmen, Arlan Richardson & Sathyaseelan S. Deepa. (2022) Senolytic treatment reduces cell senescence and necroptosis in Sod1 knockout mice that is associated with reduced inflammation and hepatocellular carcinoma. Aging Cell 21:8.
Crossref
Yikai Wang, Muqi Wang, Chenrui Liu, Wenjun Wang, Juanjuan Shi & Shuangsuo Dang. (2022) Aspirin Use and the Risk of Hepatocellular Carcinoma. Journal of Clinical Gastroenterology 56:7, pages e293-e302.
Crossref
Luca G. Guidotti, Carlo La Vecchia & Massimo Colombo. (2022) Low‐dose aspirin reduces the risk of HBV‐associated HCC even when administered short‐term: Too good to be true?. Hepatology 76:2, pages 300-302.
Crossref
Mengshi Yi, Xi Feng, Wei Peng, Fei Teng, Youyin Tang & Zheyu Chen. (2022) Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease. European Journal of Clinical Pharmacology 78:4, pages 647-656.
Crossref
Xueliang Zhou, Tengfei Zhang, Yali Sun, Chunwei Li, Xianfei Ding, Yanhui Zhu, Lifeng Li & Zhirui Fan. (2022) Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma. Frontiers in Pharmacology 13.
Crossref
Jeng-Wei Lu, Liang-In Lin, Yuxi Sun, Dong Liu & Zhiyuan Gong. (2022) Effect of Lipopolysaccharides on Liver Tumor Metastasis of twist1a/krasV12 Double Transgenic Zebrafish. Biomedicines 10:1, pages 95.
Crossref
Yuwei Liu, Tianqi Ren, Xiaotong Xu & Jinglan Jin. (2021) Association of aspirin and nonaspirin NSAIDs therapy with the incidence risk of hepatocellular carcinoma: a systematic review and meta-analysis on cohort studies. European Journal of Cancer Prevention 31:1, pages 35-43.
Crossref
Wei Peng, Chuan Li, Xiaoyun Zhang, Tianfu Wen & Zheyu Chen. (2021) The impact of thrombocytopenia on prognosis of HBV-related small hepatocellular carcinoma: a propensity score matching analysis. World Journal of Surgical Oncology 19:1.
Crossref
Xiaofei Li, Yuexiao Yu & Liwen Liu. (2021) Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis. Clinics and Research in Hepatology and Gastroenterology 45:6, pages 101545.
Crossref
Leonardo Gomes Da Fonseca & Alejandro Forner. (2021) Editorial: aspirin and NSAID for chemoprevention of hepatocellular carcinoma—ready for their use?. Alimentary Pharmacology & Therapeutics 54:6, pages 850-851.
Crossref
Regina Zi Hwei Tan, Ian Lockart, Christina Abdel Shaheed & Mark Danta. (2021) Systematic review with meta‐analysis: The effects of non‐steroidal anti‐inflammatory drugs and anti‐platelet therapy on the incidence and recurrence of hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 54:4, pages 356-367.
Crossref
Emanuela Ricciotti, Kirk J. Wangensteen & Garret A. FitzGerald. (2021) Aspirin in Hepatocellular Carcinoma. Cancer Research 81:14, pages 3751-3761.
Crossref
Qing Li, Rong Cong, Yuting Wang, Fanfei Kong, Jian Ma, Qijun Wu & Xiaoxin Ma. (2021) Naples prognostic score is an independent prognostic factor in patients with operable endometrial cancer: Results from a retrospective cohort study. Gynecologic Oncology 160:1, pages 91-98.
Crossref
Zoe N. Memel, Ashwini Arvind, Oluwatoba Moninuola, Lisa Philpotts, Raymond T. Chung, Kathleen E. Corey & Tracey G. Simon. (2020) Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta‐analysis. Hepatology Communications 5:1, pages 133-143.
Crossref
Maria Narożna, Violetta Krajka-Kuźniak, Barbara Bednarczyk-Cwynar, Robert Kleszcz & Wanda Baer-Dubowska. (2020) The Effect of Novel Oleanolic Acid Oximes Conjugated with Indomethacin on the Nrf2-ARE And NF-κB Signaling Pathways in Normal Hepatocytes and Human Hepatocellular Cancer Cells. Pharmaceuticals 14:1, pages 32.
Crossref
Maria Grazia Refolo, Caterina Messa, Vito Guerra, Brian Irving Carr & Rosalba D’Alessandro. (2020) Inflammatory Mechanisms of HCC Development. Cancers 12:3, pages 641.
Crossref
Monia Marchetti, Arianna Ghirardi, Arianna Masciulli, Alessandra Carobbio, Francesca Palandri, Nicola Vianelli, Elena Rossi, Silvia Betti, Ambra Di Veroli, Alessandra Iurlo, Daniele Cattaneo, Guido Finazzi, Massimiliano Bonifacio, Luigi Scaffidi, Andrea Patriarca, Elisa Rumi, Ilaria Carola Casetti, Clemency Stephenson, Paola Guglielmelli, Elena Maria Elli, Miroslava Palova, Davide Rapezzi, Daniel Erez, Montse Gomez, Kai Wille, Manuel Perez‐Encinas, Francesca Lunghi, Anna Angona, Maria Laura Fox, Eloise Beggiato, Giulia Benevolo, Giuseppe Carli, Rossella Cacciola, Mary Frances McMullin, Alessia Tieghi, Valle Recasens, Susanne Isfort, Fabrizio Pane, Valerio De Stefano, Martin Griesshammer, Alberto Alvarez‐Larran, Alessandro Maria Vannucchi, Alessandro Rambaldi & Tiziano Barbui. (2019) Second cancers in MPN: Survival analysis from an international study. American Journal of Hematology 95:3, pages 295-301.
Crossref
Hou-Chuan Lai, Meei-Shyuan Lee, Chin Lin, Kuen-Tze Lin, Yi-Hsuan Huang, Chih-Shung Wong, Shun-Ming Chan & Zhi-Fu Wu. (2019) Propofol-based total intravenous anaesthesia is associated with better survival than desflurane anaesthesia in hepatectomy for hepatocellular carcinoma: a retrospective cohort study. British Journal of Anaesthesia 123:2, pages 151-160.
Crossref
Decebal Fodor, Ioan Jung, Sabin Turdean, Catalin Satala & Simona Gurzu. (2019) Angiogenesis of hepatocellular carcinoma: An immunohistochemistry study. World Journal of Hepatology 11:3, pages 294-304.
Crossref